Evidence map›Paper›PMID 41249960›Full record

ArticleBMC medical imaging2025

SegResDeiT: a hybrid SegNet-ResNet-50-DeiT framework for automated cervical cancer segmentation and classification.

Aaseegha M D, Venkataramana B

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aaseegha M DDepartment of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Venkataramana BDepartment of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India. venkataramana.b@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prompt and precise identification of cervical cancer via cytology screening is essential for decreasing mortality; yet, traditional manual microscopy is impeded by subjectivity, operator tiredness, and limited throughput, resulting in diagnostic discrepancies. Conventional deep learning models have been investigated for automation; however, these methods frequently encounter difficulties in reconciling accurate spatial boundary segmentation with effective global contextual reasoning, thereby constraining their clinical precision and dependability. This paper introduces SegResDeiT, an innovative hybrid framework designed for the concurrent segmentation and classification of cervical cytology images. Our model incorporates a SegNet backbone for precise pixel-wise segmentation, a ResNet-50 encoder for hierarchical feature extraction, and a Data-efficient Image Transformer (DeiT) head for enhanced global context modelling and classification. The proposed model underwent thorough evaluation against leading benchmarks, achieving exceptional performance with an accuracy of 94.47%, precision of 95.66%, recall of 96.47%, F1-score of 96.06%, and outstanding segmentation quality, as demonstrated by a Dice coefficient of 96.06% and an IoU of 92.43%. An ablation investigation validated the collaborative impact of each architectural element, while a computational analysis illustrated a feasible equilibrium between superior performance and practical inference duration. The results unequivocally indicate that SegResDeiT outperforms current methodologies, providing a reliable and effective alternative likely to improve the precision and availability of automated cervical cancer screening, with considerable prospects for practical use.

Indexed as

Deep LearningImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedUterine Cervical NeoplasmsAlgorithmsConvolutional Neural NetworksFemaleHumansCervical cancer (CC)Cervical cancer cytologyDeep learningDeiTHistopathologyImage segmentationMedical AIResNet-50SegNet

Identifiers

PMID41249960
PMCPMC12625023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.